We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Oscar Health, Inc. (OSCR) Rises Higher Than Market: Key Facts
Read MoreHide Full Article
Oscar Health, Inc. (OSCR - Free Report) closed at $11.73 in the latest trading session, marking a +2.27% move from the prior day. The stock exceeded the S&P 500, which registered a gain of 0.72% for the day. Meanwhile, the Dow experienced a rise of 0.48%, and the technology-dominated Nasdaq saw an increase of 1.16%.
Prior to today's trading, shares of the company had lost 16.09% lagged the Finance sector's loss of 5.41% and the S&P 500's loss of 4.99%.
Investors will be eagerly watching for the performance of Oscar Health, Inc. in its upcoming earnings disclosure. In that report, analysts expect Oscar Health, Inc. to post earnings of $1.21 per share. This would mark year-over-year growth of 31.52%. Our most recent consensus estimate is calling for quarterly revenue of $4.89 billion, up 60.62% from the year-ago period.
For the full year, the Zacks Consensus Estimates project earnings of $0.2 per share and a revenue of $18.91 billion, demonstrating changes of +111.83% and +61.62%, respectively, from the preceding year.
It is also important to note the recent changes to analyst estimates for Oscar Health, Inc. Recent revisions tend to reflect the latest near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, there's been no change in the Zacks Consensus EPS estimate. At present, Oscar Health, Inc. boasts a Zacks Rank of #3 (Hold).
Digging into valuation, Oscar Health, Inc. currently has a Forward P/E ratio of 56.41. This indicates a premium in contrast to its industry's Forward P/E of 9.37.
The Insurance - Multi line industry is part of the Finance sector. At present, this industry carries a Zacks Industry Rank of 152, placing it within the bottom 38% of over 250 industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Oscar Health, Inc. (OSCR) Rises Higher Than Market: Key Facts
Oscar Health, Inc. (OSCR - Free Report) closed at $11.73 in the latest trading session, marking a +2.27% move from the prior day. The stock exceeded the S&P 500, which registered a gain of 0.72% for the day. Meanwhile, the Dow experienced a rise of 0.48%, and the technology-dominated Nasdaq saw an increase of 1.16%.
Prior to today's trading, shares of the company had lost 16.09% lagged the Finance sector's loss of 5.41% and the S&P 500's loss of 4.99%.
Investors will be eagerly watching for the performance of Oscar Health, Inc. in its upcoming earnings disclosure. In that report, analysts expect Oscar Health, Inc. to post earnings of $1.21 per share. This would mark year-over-year growth of 31.52%. Our most recent consensus estimate is calling for quarterly revenue of $4.89 billion, up 60.62% from the year-ago period.
For the full year, the Zacks Consensus Estimates project earnings of $0.2 per share and a revenue of $18.91 billion, demonstrating changes of +111.83% and +61.62%, respectively, from the preceding year.
It is also important to note the recent changes to analyst estimates for Oscar Health, Inc. Recent revisions tend to reflect the latest near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, there's been no change in the Zacks Consensus EPS estimate. At present, Oscar Health, Inc. boasts a Zacks Rank of #3 (Hold).
Digging into valuation, Oscar Health, Inc. currently has a Forward P/E ratio of 56.41. This indicates a premium in contrast to its industry's Forward P/E of 9.37.
The Insurance - Multi line industry is part of the Finance sector. At present, this industry carries a Zacks Industry Rank of 152, placing it within the bottom 38% of over 250 industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.